Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Change in Accured Expenses (2018 - 2025)

Historic Change in Accured Expenses for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $633000.0.

  • Bio's Change in Accured Expenses fell 6186.75% to $633000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $255000.0, marking a year-over-year decrease of 8611.87%. This contributed to the annual value of -$1.8 million for FY2024, which is 14330.86% down from last year.
  • Bio's Change in Accured Expenses amounted to $633000.0 in Q3 2025, which was down 6186.75% from $1.4 million recorded in Q2 2025.
  • Bio's Change in Accured Expenses' 5-year high stood at $2.8 million during Q4 2023, with a 5-year trough of -$3.5 million in Q1 2024.
  • Moreover, its 5-year median value for Change in Accured Expenses was $1.0 million (2021), whereas its average is $449315.8.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 113652.69% in 2021, then tumbled by 13002.85% in 2024.
  • Quarter analysis of 5 years shows Bio's Change in Accured Expenses stood at $1.1 million in 2021, then skyrocketed by 43.88% to $1.6 million in 2022, then skyrocketed by 75.25% to $2.8 million in 2023, then crashed by 130.03% to -$842000.0 in 2024, then skyrocketed by 175.18% to $633000.0 in 2025.
  • Its last three reported values are $633000.0 in Q3 2025, $1.4 million for Q2 2025, and -$930000.0 during Q1 2025.